Itay & Beyond Overview
Itay & Beyond is a pioneering biotech startup revolutionizing neuropsychiatric drug discovery through its platform. The company is driven by the urgent need for more effective treatments in neuropsychiatry.
Latest News
Biotech startup Itay & Beyond uses AI analysis of a ‘brain-on-a-chip’ made from stem cells to predict drug efficacy for neuropsychiatric disorders, expedite testing and development
growth-positive
Autism, epilepsy meet next-gen medicine with Israel’s brain chip innovation
Itay and Beyond, an Israeli start-up, is pioneering a new approach to drug discovery for neurological and psychiatric disorders using brain organoids and a 3D brain on a chip technology. This innovative platform, which combines patient-derived brain organoids with advanced AI technology, aims to improve the success rate of translating preclinical studies to clinical trials. The company is focusing on disorders such as autism, epilepsy, and schizophrenia, working in collaboration with medical centers like Hadassah-University Medical Center and Schneider Childrens Medical Center. The technology has attracted interest from pharmaceutical companies due to its potential to revolutionize drug development. Clinical testing for existing drugs could begin within 18 months, highlighting the platforms potential for rapid impact.
Product StagePartners
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Pre-Funding |
| Rounds | 0 |
| Investors | 0 |
Team Members
2
Employees: 11-50
Web & Social Links
| Website | itayandbeyond.com/ |
Locations
Jerusalem, Israel
Photos & Videos
No files yet
Itay & Beyond Business
Business models
—
Product stage
R&D
Employees
11-50
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentDigital HealthcareTarget Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnologyHealthcarePatientsCore Technology
—Tags (2)
drug-discoveryneuroscienceItay & Beyond Financials
Undisclosed
Total funding
—
Capital raised
Undisclosed
Last funding
Pre-Funding
Funding stage
0
Total rounds
0
Investors
Itay & Beyond Lifecycle
Itay & Beyond News
2 articlesBiotech startup Itay & Beyond uses AI analysis of a ‘brain-on-a-chip’ made from stem cells to predict drug efficacy for neuropsychiatric disorders, expedite testing and development
growth-positive
Autism, epilepsy meet next-gen medicine with Israel’s brain chip innovation
Itay and Beyond, an Israeli start-up, is pioneering a new approach to drug discovery for neurological and psychiatric disorders using brain organoids and a 3D brain on a chip technology. This innovative platform, which combines patient-derived brain organoids with advanced AI technology, aims to improve the success rate of translating preclinical studies to clinical trials. The company is focusing on disorders such as autism, epilepsy, and schizophrenia, working in collaboration with medical centers like Hadassah-University Medical Center and Schneider Childrens Medical Center. The technology has attracted interest from pharmaceutical companies due to its potential to revolutionize drug development. Clinical testing for existing drugs could begin within 18 months, highlighting the platforms potential for rapid impact.
Product StagePartners
Employee Info
| Employees (range) | 11-50 |
| Exact count | 15 |
| Team members | 2 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 10 classification IDs that could be used for matching.
Itay & Beyond Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 60/100 |
| Missing | sector, tags, business model, description, video or image, funding rounds, markets, not claimed |
| BI Verification | Matan Eblagon |
| Creator | Matan Eblagon |
| Creator email | matane@sncentral.org |
| Last update | 2025-03-05T00:00:00.000Z |
| Created | 2025-03-05T00:00:00.000Z |